ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Aurélie Thollet et al.|Cancer Research|2012Cited by 131
The critical role of the <scp>ZNF217</scp> oncogene in promoting breast cancer metastasis to the boneAurélie Bellanger, Pascale A. Cohen, Caterina F. Donini et al.|The Journal of Pathology|2017Cited by 55
VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loopAsma Boudria, Béatrice Eymin, Chérine Abou Fayçal et al.|Oncogene|2018Cited by 52
LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast CancersChloé Prunier, Laurence Lafanéchère, Véronique Josserand et al.|Cancer Research|2016Cited by 34
The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in MiceJulien Vollaire, Pascale A. Cohen, Irma Machuca‐Gayet et al.|Frontiers in Pharmacology|2019Cited by 32